PKC and the control of localized signal dynamics

Nature Reviews Molecular Cell Biology

Volumn 11, Issue 2, 2010, Pages 103-112

  Rosse, Carine ^a   Linch, Mark ^a   Kermorgant, Stéphanie ^b   Cameron, Angus J M ^a   Boeckeler, Katrina ^a   Parker, Peter J ^a,b  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR; GUANOSINE TRIPHOSPHATASE; ISOENZYME; ISOPROTEIN; PROTEIN CDC42; PROTEIN KINASE; PROTEIN KINASE C; T LYMPHOCYTE RECEPTOR;

ANTIGEN PRESENTING CELL; CARBOXY TERMINAL SEQUENCE; CELL ACTIVITY; CELL CONTACT; CELL DIFFERENTIATION; ENZYME ACTIVITY; HUMAN; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANIMALS; CELL COMMUNICATION; CELL MOVEMENT; HUMANS; ISOENZYMES; PROTEIN KINASE C; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

EID: 75149161903     PISSN: 14710072     EISSN: 14710080     Source Type: Journal    
DOI: 10.1038/nrm2847     Document Type: Review

References (123)

1. Velculescu, V. E. Defining the blueprint of the cancer genome. Carcinogenesis 29, 1087-1091 (2008).
2. Capdeville, R., Buchdunger, E., Zimmermann, J. & Matter, A. Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug. Nature Rev. Drug Discov. 1, 493-502 (2002).
3. DeLange, R. J., Kemp, R. G., Riley, W. D., Cooper, R. A. & Krebs, E. G. Activation of skeletal muscle phosphorylase kinase by adenosine triphosphate and adenosine 3', 5'-monophosphate. J. Biol. Chem. 243, 2200-2208 (1968).
4. Elion, E. A. The Ste5p scaffold. J. Cell Sci. 114, 3967-3978 (2001).
5. Carnegie, G. K., Smith, F D., McConnachie, G., Langeberg, L. K. & Scott, J. D. AKAP-Lbc nucleates a protein kinase D activation scaffold. Mol. Cell 15, 889-899 (2004).
6. Pawson, T. Regulation and targets of receptor tyrosine kinases. Eur. J. Cancer 38, S3-S10 (2002).
7. Perkins, G. A. et al. PKA, PKC, and AKAP localization in and around the neuromuscular junction. BMC Neurosci. 2, 17 (2001)
8. Shieh, B. h., Parker, L. & Popescu, D. Protein kinase C (PKC) isoforms in Drosophila. J. Biochem. 132, 523-527 (2002).
9. Sim, A. T. & Scott, J. D. Targeting of, PKA, PKC and protein phosphatases to cellular microdomains. Cell Calcium 26, 209-217 (1999).
10. Csukai, M. & Mochly-Rosen, D. Pharmacologic modulation of protein kinase C isozymes: the role of RACKs and subcellular localisation. Pharmacol. Res. 39, 253-259 (1999).
11. Jaken, S. & Parker, P. J. Protein kinase C binding partners. Bioessays 22, 245-254 (2000).
12. Poole, A. W., Pula, G., hers, I., Crosby, D. & Jones, M. L. PKC-interacting proteins: from function to pharmacology. Trends Pharmacol. Sci. 25, 528-535 (2004).
13. Mellor, h. & Parker, P. J. The extended protein kinase C superfamily. Biochem. J. 332, 281-292 (1998).
14. Leitges, M. Functional PKC in vivo analysis using deficient mouse models. Biochem. Soc. Trans. 35, 1018-1020 (2007).
15. Pears, C. J., Kour, G., house, C, Kemp, B. E. & Parker, P. J. Mutagenesis of the pseudosubstrate site of protein kinase C leads to activation. Eur J. Biochem. 194, 89-94 (1990).
16. Nalefski, E. A. & Newton, A. C. Membrane binding kinetics of protein kinase C (3II mediated by the C2 domain. Biochemistry 40, 13216-13229 (2001).
17. Oancea, E. & Meyer, T Protein kinase C as a molecular machine for decoding calcium and diacylglycerol signals. Cell 95, 307-318 (1998).
18. Suzuki, A. et al. Atypical protein kinase C is involved in the evolutionary conserved par protein complex and plays a critical role in establishing epithelia-specific junctional structures. J. Cell Biol. 152, 1183-1196 (2001).
19. Flynn, P., Mellor, h., Palmer, R., Panayotou, G. & Parker, P. J. Multiple interactions of PRK1 with RhoA. Functional assignment of the hr1 repeat motif. J. Biol. Chem. 273, 2698-2705 (1998).
20. Shibata, h. et al. Characterization of the interaction between RhoA and the amino-terminal region of PKN. FEBS Lett. 385 221-224 (1996). (Pubitemid 26167461)
21. Lim, W. G. et al. The very C-terminus of PRK1 /PKN is essential for its activation by RhoA and downstream signaling. Cell Signal. 18, 1473-1481 (2006).
22. Triantafilou, K., Triantafilou, M. & Fernandez, N. Molecular associations and microdomains in antigen-presenting cell-T-cell interactions. Crit. Rev. Immunol. 20, 359-373 (2000).
23. Martin, P. et al. Control of T helper 2 cell function and allergic airway inflammation by PKCC Proc. Natl Acad Sci. USA 102, 9866-9871 (2005).
24. Yang, J. Q., Leitges, M., Duran, A., Diaz-Meco, M. T. & Moscat, J. Loss of PKC A/i impairs Th2 establishment and allergic airway inflammation in vivo. Proc. Natl Acad. Sci. USA 106, 1099-1104 (2009).
25. Baier, G. et al. Molecular-cloning and characterization of pkc-8, a novel member of protein kinase c (pkc) gene family expressed predominantly in hematopoietic cells. J. Biol. Chem. 268, 4997-5004 (1993).
26. Osada, S. et al. A new member of the protein kinase C family, nPKC theta, predominantly expressed in skeletal muscle. Mol. Cell. Biol. 12, 3930-3938 (1992).
27. Manicassamy, S., Gupta, S. & Sun, Z. Selective function of PKC-8 in T cells. Cell. Mol. Immunol. 3, 263-270 (2006).
28. Marsland, B. J., Soos, T. J., Spath, G., Littman, D. R. & Kopf, M. Protein kinase C 8 is critical for the development of in vivo T helper (Th)2 cell but not Th1 cell responses. J. Exp. Med. 200, 181-189 (2004).
29. + T cell effector and memory responses. Proc. Natl Acad. Sci. USA 102, 14374-14379 (2005).
30. Marsland, B. J. & Kopf, M. T-cell fate and function: PKC-8 and beyond. Trends Immunol. 29, 179-185 (2008).
31. Rao, K. L, Varalakshmi, C, Kumari, A. L. & Khar, A. Interaction between B.7 and CD28 costimulatory molecules is essential for the activation of effector function mediating spontaneous tumour regression. Scand. J. Immunol. 49, 633-640 (1999).
32. Monks, C. R., Freiberg, B. A., Kupfer, h., Sciaky, N. & Kupfer, A. Three-dimensional segregation of supramolecular activation clusters in T cells. Nature 395, 82-86 (1998).
33. Altman, A. & Villalba, M. Protein kinase C-8 (PKC8): it's all about location, location, location. Immunol. Rev 192, 53-63 (2003).
34. Freiberg, B. A. et al. Staging and resetting T cell activation in SMACs. Nature Immunol. 3, 911-917 (2002).
35. Schaefer, B. C, Kappler, J. W., Kupfer, A. & Marrack, P. Complex and dynamic redistribution of NF-KB signaling intermediates in response to T cell receptor stimulation. Proc. Natl Acad. Sci. USA 101, 1004-1009 (2004).
36. Sommer, K. et al. Phosphorylation of the CARMA1 linker controls NF-KB activation. Immunity 23, 561-574 (2005).
37. Liu, Y. et al. Regulation of protein kinase C8 function during T cell activation by Lck-mediated tyrosine phosphorylation. J. Biol. Chem. 275, 3603-3609 (2000).
38. Thuille, N. et al. Critical role of novel Thr-219 autophosphorylation for the cellular function of PKC8 in T lymphocytes. EMBO J. 24, 3869-3880 (2005).
39. hayashi, K. & Altman, A. Protein kinase C 8 (PKC 8): a key player in T cell life and death. Pharmacol. Res. 55, 537-544 (2007).
40. Dustin, M. L. T-cell activation through immunological synapses and kinapses. Immunol. Rev. 221, 77-89 (2008).
41. Tepass, U., Theres, C. & Knust, E. crumbs encodes an EGF-like protein expressed on apical membranes of Drosophila epithelial cells and required for organization of epithelia. Cell 61, 787-799 (1990).
42. hung, T. J. & Kemphues, K. J. PAR-6 is a conserved PDZ domain-containing protein that colocalizes with PAR-3 in Caenorhabditis elegans embryos. Development 126, 127-135 (1999).
43. Tabuse, Y et al. Atypical protein kinase C cooperates with PAR-3 to establish embryonic polarity in Caenorhabditis elegans. Development 125, 3607-3614 (1998).
44. Watts, J. L. et al. par-6, a gene involved in the establishment of asymmetry in early C. elegans embryos, mediates the asymmetric localization of PAR-3. Development 122, 3133-3140 (1996).
45. horikoshi, Y et al. Interaction between PAR-3 and the aPKC-PAR-6 complex is indispensable for apical domain development of epithelial cells. J. Cell Sci. 122, 1595-1606 (2009).
46. Joberty, G., Petersen, C, Gao, L. & Macara, I. G. The cell-polarity protein Par6 links Par3 and atypical protein kinase C to Cdc42. Nature Cell Biol. 2, 531-539 (2000).
47. Izumi, Y. et al. An atypical PKC directly associates and colocalizes at the epithelial tight junction with ASIP, a mammalian homologue of Caenorhabditis elegans polarity protein PAR-3. J. Cell Biol. 143, 95-106 (1998).
48. Kemphues, K. J., Priess, J. R., Morton, D. G. & Cheng, N. S. Identification of genes required for cytoplasmic localization in early C. elegans embryos. Cell 52, 311-320 (1988).
49. Kemphues, K. PARsing embryonic polarity. Cell 101, 345-348 (2000).
50. Ono, Y et al. Protein kinase C t subspecies from rat brain: its structure, expression, and properties. Proc. Natl Acad. Sci. USA 86, 3099-3103 (1989). (Pubitemid 19129566)
51. Moscat, J., Diaz-Meco, M. T, Albert, A. & Campuzano, S. Cell signaling and function organized by PB1 domain interactions. Mol. Cell 23, 631-640 (2006).
52. Lin, D. et al. A mammalian PAR-3-PAR-6 complex implicated in Cdc42/Rac 1 and aPKC signalling and cell polarity. Nature Cell Biol. 2, 540-547 (2000).
53. Yamanaka, T. et al. PAR-6 regulates aPKC activity in a novel way and mediates cell-cell contact-induced formation of the epithelial junctional complex. Genes Cells 6, 721-731 (2001).
54. Bilder, D., Schober, M. & Perrimon, N. Integrated activity of PDZ protein complexes regulates epithelial polarity. Nature Cell Biol. 5, 53-58 (2003).
55. hirose, T. et al. Involvement of ASIP/PAR-3 in the promotion of epithelial tight junction formation. J. Cell Sci. 115, 2485-2495 (2002).
56. Takekuni, K. et al. Direct binding of cell polarity protein PAR-3 to cell-cell adhesion molecule nectin at neuroepithelial cells of developing mouse. J. Biol. Chem. 278, 5497-5500 (2003).
57. Ebnet, K. et al. The cell polarity protein ASIP/PAR-3 directly associates with junctional adhesion molecule (JAM). EMBO J. 20, 3738-3748 (2001).
58. Mizuno, K. et al. Self-association of PAR-3-mediated by the conserved N-terminal domain contributes to the development of epithelial tight junctions. J. Biol. Chem. 278, 31240-31250 (2003).
59. Yamanaka, T. et al. Mammalian Lgl forms a protein complex with PAR-6 and aPKC independently of PAR-3 to regulate epithelial cell polarity. Curr. Biol. 13, 734-743 (2003).
60. Betschinger, J., Mechtler, K. & Knoblich, J. A. The Par complex directs asymmetric cell division by phosphorylating the cytoskeletal protein Lgl. Nature 422, 326-330 (2003).
61. Yamanaka, T. et al. Lgl mediates apical domain disassembly by suppressing the PAR-3-aPKC-PAR-6 complex to orient apical membrane polarity. J. Cell Sci. 119, 2107-2118 (2006).
62. Betschinger, J., Eisenhaber, F & Knoblich, J. A. Phosphorylation- induced autoinhibition regulates the cytoskeletal protein Lethal (2) giant larvae. Curr. Biol. 15, 276-282 (2005).
63. hutterer, A., Betschinger, J., Petronczki, M. & Knoblich, J. A. Sequential roles of Cdc42, Par-6, aPKC, and Lgl in the establishment of epithelial polarity during Drosophila embryogenesis. Dev Cell 6, 845-854 (2004).
64. Bialucha, C. U., Ferber, E. C, Pichaud, F, Peak-Chew, S. Y. & Fujita, Y. p32 is a novel mammalian Lgl binding protein that enhances the activity of protein kinase Ci; and regulates cell polarity. J. Cell Biol. 178, 575-581 (2007).
65. Kallay, L. M., McNickle, A., Brennwald, P. J., hubbard, A. L. & Braiterman, L. T Scribble associates with two polarity proteins, Lgl2 and Vangl2, via distinct molecular domains. J. Cell. Biochem. 99, 647-664 (2006).
66. Bilder, D. & Perrimon, N. Localization of apical epithelial determinants by the basolateral PDZ protein Scribble. Nature 403, 676-680 (2000).
67. Musch, A. et al. Mammalian homolog of Drosophila tumor suppressor lethal (2) giant larvae interacts with basolateral exocytic machinery in Madin-Darby canine kidney cells. Mol. Biol. Cell 13, 158-168 (2002).
68. Eder, A. M. et al. Atypical PKCi contributes to poor prognosis through loss of apical-basal polarity and cyclin E overexpression in ovarian cancer. Proc. Natl Acad. Sci. USA 102, 12519-12524 (2005).
69. Fields, A. P. & Regala, R. P. Protein kinase C i: human oncogene, prognostic marker and therapeutic target. Pharmacol. Res. 55, 487-497 (2007).
70. Kojima, Y. et al. The overexpression and altered localization of the atypical protein kinase C X/i in breast cancer correlates with the pathologic type of these tumors. Hum. Pathol. 39, 824-831 (2008).
71. Regala, R. P. et al. Atypical protein kinase Ci plays a critical role in human lung cancer cell growth and tumorigenicity. J. Biol. Chem. 280, 31109-31115 (2005).
72. Nolan, M. E. et al. The polarity protein Par6 induces cell proliferation and is overexpressed in breast cancer. Cancer Res. 68, 8201-8209 (2008).
73. Larsson, C. Protein kinase C and the regulation of the actin cytoskeleton. Cell Signal. 18, 276-284 (2006).
74. Keum, E. et al. Syndecan-4 regulates localization, activity and stability of protein kinase C-a. Biochem. J. 378, 1007-1014 (2004).
75. Ng, T. et al. PKCa regulates p1 integrin-dependent cell motility through association and control of integrin traffic. EMBO J. 18, 3309-3923 (1999).
76. Ivaska, J., Whelan, R. D., Watson, R. & Parker, P. J. PKCs controls the traffic of (31 integrins in motile cells. EMBO J. 21, 3608-3619 (2002).
77. Legg, J. W., Lewis, C. A., Parsons, M., Ng, T & Isacke, C. M. A novel PKC-regulated mechanism controls CD44 ezrin association and directional cell motility. Nature Cell Biol. 4, 399-407 (2002).
78. Kalomiris, E. L. & Bourguignon, L. Y. Lymphoma protein kinase C is associated with the transmembrane glycoprotein, GP85, and may function in GP85-ankyrin binding. J. Biol. Chem. 264, 8113-8119 (1989)
79. hood, J. D. & Cheresh, D. A. Role of integrins in cell invasion and migration. Nature Rev. Cancer 2, 91-100 (2002).
80. Birchmeier, C, Birchmeier, W., Gherardi, E. & Vande Woude, G. F Met, metastasis, motility and more. Nature Rev. Mol. Cell Biol. 4, 915-925 (2003).
81. Lengyel, E., Sawada, K. & Salgia, R. Tyrosine kinase mutations in human cancer. Curr. Mol. Med. 7, 77-84 (2007).
82. Ma, P. C, Maulik, G., Christensen, J. & Salgia, R. c-Met: structure, functions and potential for therapeutic inhibition. Cancer Metastasis Rev. 22, 309-325 (2003).
83. Trusolino, L. & Comoglio, P. M. Scatter-factor and semaphorin receptors: cell signalling for invasive growth. Nature Rev. Cancer 2, 289-300 (2002).
84. Kermorgant, S., Zicha, D. & Parker, P. J. Protein kinase C controls microtubule-based traffic but not proteasomal degradation of c-Met. J. Biol. Chem. 278, 28921-28929 (2003)
85. hammond, D. E., Carter, S. & Clague, M. J. Met receptor dynamics and signalling. Curr. Top. Microbiol. Immunol. 286, 21-44 (2004).
86. Vieira, A. V., Lamaze, C. & Schmid, S. L. Control of EGF receptor signaling by clathrin-mediated endocytosis. Science 274, 2086-2089 (1996).
87. Chow, J. C, Condorelli, G. & Smith, R. J. Insulin-like growth factor-I receptor internalization regulates signaling via the Shc/mitogen-activated protein kinase pathway, but not the insulin receptor substrate-1 pathway. J. Biol. Chem. 273, 4672-4680 (1998).
88. Zhang, Y, Moheban, D. B., Conway, B. R., Bhattacharyya, A. & Segal, R. A. Cell surface Trk receptors mediate NGF-induced survival while internalized receptors regulate NGF-induced differentiation. J. Neurosci. 20, 5671-5678 (2000)
89. howe, C. L, Valletta, J. S., Rusnak, A. S. & Mobley, W. C. NGF signaling from clathrin-coated vesicles: evidence that signaling endosomes serve as a platform for the Ras-MAPK pathway. Neuron 32, 801-814 (2001).
90. Hayes, S., Chawla, A. & Corvera, S. TGF (3 receptor internalization into EEA1-enriched early endosomes: role in signaling to Smad2. J. Cell Biol. 158 1239-1249 (2002).
91. Kermorgant, S., Zicha, D. & Parker, P. J. PKC controls hGF-dependent c-Met traffic, signalling and cell migration. EMBO J. 23, 3721-3734 (2004)
92. hashigasako, A., Machide, M., Nakamura, T, Matsumoto, K. & Nakamura, T Bi-directional regulation of Ser-985 phosphorylation of c-met via protein kinase C and protein phosphatase 2A involves c-Met activation and cellular responsiveness to hepatocyte growth factor. J. Biol. Chem. 279, 26445-26452 (2004).
93. 3 integrin and regulates cell spreading on vitronectin. J. Biol. Chem. 278, 1975-1985 (2003).
94. Alvi, F, Idkowiak-Baldys, J., Baldys, A., Raymond, J. R. & hannun, Y A. Regulation of membrane trafficking and endocytosis by protein kinase C: emerging role of the pericentrion, a novel protein kinase C-dependent subset of recycling endosomes. Cell. Mol. Life Sci. 64, 263-270 (2007). (Pubitemid 46440202)
95. Kermorgant, S. & Parker, P. J. Receptor trafficking controls weak signal delivery: a strategy used by c-Met for STAT3 nuclear accumulation. J. Cell Biol. 182, 855-863 (2008).
96. Welchman, D. P., Mathies, L. D. & Ahringer, J. Similar requirements for CDC-42 and the PAR-3/ PAR-6/PKC-3 complex in diverse cell types. Dev Biol. 305, 347-357 (2007)
97. hyodo-Miura, J. et al. XGAP, an ArfGAP, is required for polarized localization of PAR proteins and cell polarity in Xenopus gastrulation. Dev. Cell 11, 69-79 (2006).
98. Pinheiro, E. M. & Montell, D. J. Requirement for Par-6 and Bazooka in Drosophila border cell migration. Development 131, 5243-5251 (2004).
99. Rosse, C, Formstecher, E., Boeckeler, K., Zhao, Y., Kremerskothen, J., White, M., Camonis, J. & Parker, P. J. An aPKC-Exocyst complex controls Paxillin phosphorylation and migration through localised JNK1 activation. PLoS Biol. 7, e1000235 (2009).
100. Rosse, C. et al. RalB mobilizes the exocyst to drive cell migration. Mol. Cell. Biol. 26, 727-734 (2006).
101. Cau, J. & hall, A. Cdc42 controls the polarity of the actin and microtubule cytoskeletons through two distinct signal transduction pathways. J. Cell Sci. 118, 2579-2587 (2005).
102. Schlessinger, K., McManus, E. J. & hall, A. Cdc42 and noncanonical Wnt signal transduction pathways cooperate to promote cell polarity. J. Cell Biol. 178, 355-361 (2007).
103. Etienne-Manneville, S. & hall, A. Integrin-mediated activation of Cdc42 controls cell polarity in migrating astrocytes through PKCC Cell 106, 489-498 (2001).
104. Etienne-Manneville, S. & hall, A. Cdc42 regulates GSK-3(3 and adenomatous polyposis coli to control cell polarity. Nature 421, 753-756 (2003).
105. Etienne-Manneville, S., Manneville, J. B., Nicholls, S., Ferenczi, M. A. & hall, A. Cdc42 and Par6-PKCi; regulate the spatially localized association of Dlg 1 and APC to control cell polarization. J. Cell Biol. 170, 895-901 (2005).
106. Meyer, T. & Teruel, M. N. Fluorescence imaging of signaling networks. Trends Cell Biol. 13, 101-106 (2003).
107. Ng, T et al. Imaging protein kinase Ca activation in cells. Science 283, 2085-2089 (1999).
108. Gallegos, L. L, Kunkel, M. T. & Newton, A. C. Targeting protein kinase C activity reporter to discrete intracellular regions reveals spatiotemporal differences in agonist-dependent signaling. J. Biol. Chem. 281, 30947-30956 (2006)
109. ho, S. N., Biggar, S. R., Spencer, D. M., Schreiber, S. L. & Crabtree, G. R. Dimeric ligands define a role for transcriptional activation domains in reinitiation. Nature 382, 822-826 (1996).
110. Fili, N., Calleja, V., Woscholski, R., Parker, P. J. & Larijani, B. Compartmental signal modulation: endosomal phosphatidylinositol 3-phosphate controls endosome morphology and selective cargo sorting. Proc. Natl Acad. Sci. USA 103, 15473-15478 (2006).
111. Varnai, P., Thyagarajan, B., Rohacs, T & Balla, T Rapidly inducible changes in phosphatidylinositol 4, 5-bisphosphate levels influence multiple regulatory functions of the lipid in intact living cells. J. Cell Biol. 175, 377-382 (2006).
112. Parekh, D. B., Ziegler, W & Parker, P. J. Multiple pathways control protein kinase C phosphorylation. EMBO J. 19, 496-503 (2000).
113. Gao, T & Newton, A. C. The turn motif is a phosphorylation switch that regulates the binding of hsp70 to protein kinase, C. J. Biol. Chem. 277, 31585-31592 (2002).
114. Cameron, A. J., Procyk, K. J., Leitges, M. & Parker, P. J. PKC a protein but not kinase activity is critical for glioma cell proliferation and survival. Int. J. Cancer 123, 769-779 (2008).
115. Chou, M. M. et al. Regulation of protein kinase C t by PI 3-kinase and PDK-1. Curr. Biol. 8, 1069-1077 (1998).
116. Le Good, J. A. et al. Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1. Science 281, 2042-2045 (1998).
117. Mora, A., Komander, D., van Aalten, D. M. & Alessi, D. R. PDK1, the master regulator of AGC kinase signal transduction. Semin. Cell Dev. Biol. 15, 161-170 (2004).
118. Facchinetti, V. et al. The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase, C. EMBO J. 27, 1932-1943 (2008).
119. Ikenoue, T., Inoki, K., Yang, Q., Zhou, X. & Guan, K. L. Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling. EMBO J. 27, 1919-1931 (2008).
120. Grodsky, N. et al. Structure of the catalytic domain of human protein kinase C p II complexed with a bisindolylmaleimide inhibitor. Biochemistry 45, 13970-13981 (2006).
121. Rhee, S. G. Regulation of phosphoinositide-specific phospholipase, C. Annu. Rev. Biochem. 70, 281-312 (2001).
122. heasman, S. J. & Ridley, A. J. Mammalian Rho GTPases: new insights into their functions from in vivo studies. Nature Rev. Mol. Cell Biol. 9, 690-701 (2008).
123. Kitagawa, M., Shibata, h., Toshimori, M., Mukai, h. & Ono, Y The role of the unique motifs in the amino-terminal region of PKN on its enzymatic activity. Biochem. Biophys. Res. Commun. 220, 963-968 (1996).